- Report
- March 2026
- 196 Pages
Global
From €3987EUR$4,500USD£3,413GBP
- Report
- February 2026
- 250 Pages
Global
From €3978EUR$4,490USD£3,405GBP
- Report
- January 2026
- 160 Pages
Global
From €2800EUR$3,160USD£2,397GBP
€3500EUR$3,950USD£2,996GBP
- Report
- February 2026
- 140 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- April 2026
- 150 Pages
Global
From €5272EUR$5,950USD£4,512GBP
- Report
- August 2026
- 187 Pages
Global
From €3141EUR$3,545USD£2,689GBP
€3490EUR$3,939USD£2,987GBP
- Report
- August 2026
- 190 Pages
Global
From €3141EUR$3,545USD£2,689GBP
€3490EUR$3,939USD£2,987GBP
- Report
- January 2026
- 198 Pages
Global
From €3141EUR$3,545USD£2,689GBP
€3490EUR$3,939USD£2,987GBP
- Report
- August 2026
- 282 Pages
Global
From €5183EUR$5,850USD£4,437GBP
- Report
- May 2026
- 436 Pages
Global
From €3978EUR$4,490USD£3,405GBP
- Report
- February 2026
- 250 Pages
Global
From €3978EUR$4,490USD£3,405GBP
- Report
- February 2026
- 250 Pages
Global
From €3978EUR$4,490USD£3,405GBP
- Report
- February 2026
- 250 Pages
Global
From €3978EUR$4,490USD£3,405GBP
- Report
- May 2026
- 180 Pages
Global
From €3987EUR$4,500USD£3,413GBP
- Report
- August 2026
- 122 Pages
Global
From €4209EUR$4,750USD£3,602GBP
- Report
- May 2026
- 150 Pages
Global
From €2391EUR$2,699USD£2,047GBP
- Report
- February 2026
- 135 Pages
Global
From €2657EUR$2,999USD£2,274GBP
€3543EUR$3,999USD£3,033GBP
- Report
- September 2025
- 210 Pages
Global
From €4426EUR$4,995USD£3,788GBP
- Report
- February 2026
- 172 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- January 2026
- 169 Pages
Global
From €4120EUR$4,650USD£3,527GBP

The Sleep Disorder Drug market is a subset of the Central Nervous System Drugs market. It includes drugs used to treat a variety of sleep disorders, such as insomnia, narcolepsy, and sleep apnea. These drugs are typically classified as hypnotics, sedatives, or anxiolytics, and can be prescribed in the form of tablets, capsules, or liquids. Commonly prescribed sleep disorder drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
The Sleep Disorder Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Sanofi, Merck, GlaxoSmithKline, Novartis, and Takeda. Other companies include Sunovion, Jazz Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more